Shares of Kenvue bounced back sharply after a tumble following Trump’s claims about Tylenol use by pregnant women.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback